Literature DB >> 29460125

Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer.

Atsushi Kohga1, Yusuke Yamamoto2, Teiichi Sugiura1, Yukiyasu Okamura1, Takaaki Ito1, Ryo Ashida1, Takeshi Aramaki3, Keiko Sasaki4, Katsuhiko Uesaka1.   

Abstract

BACKGROUND AND
PURPOSE: To perform radical resection without leaving residual cancer, surgeons must distinguish between pancreatic head cancer (PHC) and intrapancreatic bile duct cancer (IPBDC) preoperatively. The aim of this study was to establish the points of difference between these two cancers, especially on preoperative multi-detector computed tomography (MDCT) images.
METHODS: The subjects of this study were 28 patients with PHC and proven bile duct invasion who underwent pancreatoduodenectomy (PHC group) and 22 patients with IPBDC and upstream bile duct dilation (IPBDC group). We compared the preoperative clinical and radiographic features, including the bile duct angle, calculated on coronal images of MDCT, and the vascularity of the tumor.
RESULTS: The optimal cut-off values for the bile duct angle, the CT value ratio of the tumor (late arterial phase/non-enhanced), and the main pancreatic duct (MPD) ratio (diameter of MPD/diameter of parenchyma) were 110°, 3.0, and 0.2, respectively. Multivariate analysis revealed that a bile duct angle < 110°, a CT value ratio of the tumor < 3, and an MPD ratio ≥ 0.2 were independently associated with PHC.
CONCLUSIONS: A bile duct angle and CT value reflecting the vascularity of the tumor might be useful radiographic features for differentiating PHC and IPBDC, in addition to MPD dilatation.

Entities:  

Keywords:  Bile duct angulation; Differential diagnosis; Intrapancreatic bile duct cancer; Pancreatic head cancer

Mesh:

Year:  2018        PMID: 29460125     DOI: 10.1007/s00595-018-1642-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up.

Authors:  Stefano Andrianello; Salvatore Paiella; Valentina Allegrini; Marco Ramera; Alessandra Pulvirenti; Giuseppe Malleo; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2015-07-02       Impact factor: 3.445

2.  Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.

Authors:  Raul S Gonzalez; Pelin Bagci; Olca Basturk; Michelle D Reid; Serdar Balci; Jessica H Knight; So Yeon Kong; Bahar Memis; Kee-Taek Jang; Nobuyuki Ohike; Takuma Tajiri; Sudeshna Bandyopadhyay; Alyssa M Krasinskas; Grace E Kim; Jeanette D Cheng; N Volkan Adsay
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

3.  Risk factors for postoperative pancreatic fistula after pancreaticoduodenectomy: the significance of the ratio of the main pancreatic duct to the pancreas body as a predictor of leakage.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Masahiko Komagome; Nobuhiro Shin; Narihiro Cho; Takashi Ishida; Fumiaki Ozawa; Daijo Hashimoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2010-01-26       Impact factor: 7.027

4.  Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs.

Authors:  Rupert W Prokesch; Lawrence C Chow; Christopher F Beaulieu; Roland Bammer; R Brooke Jeffrey
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

Review 5.  An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Authors:  Alexander Stojadinovic; Ari Brooks; Axel Hoos; David P Jaques; Kevin C Conlon; Murray F Brennan
Journal:  J Am Coll Surg       Date:  2003-06       Impact factor: 6.113

Review 6.  Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis.

Authors:  Atsushi Masamune; Takashi Watanabe; Kazuhiro Kikuta; Tooru Shimosegawa
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

7.  Fatty Acid-Mediated Stromal Reprogramming of Pancreatic Stellate Cells Induces Inflammation and Fibrosis That Fuels Pancreatic Cancer.

Authors:  Tomoki Hata; Koichi Kawamoto; Hidetoshi Eguchi; Yoshihiro Kamada; Shinji Takamatsu; Tomohiro Maekawa; Satoshi Nagaoka; Daisaku Yamada; Yoshifumi Iwagami; Tadafumi Asaoka; Takehiro Noda; Hiroshi Wada; Kunihito Gotoh; Atsushi Masamune; Eiji Miyoshi; Masaki Mori; Yuichiro Doki
Journal:  Pancreas       Date:  2017 Nov/Dec       Impact factor: 3.327

8.  Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes.

Authors:  Na Ra Kim; Jeong Min Lee; Se Hyung Kim; Su Kyung An; Chang Jin Han; Seung Hong Choi; Joon Koo Han; Hye Seung Lee; Ja Jun Jang; Byung Ihn Choi
Journal:  Clin Imaging       Date:  2008 Mar-Apr       Impact factor: 1.605

Review 9.  Endoscopic ultrasonography guided-fine needle aspiration for the diagnosis of solid pancreaticobiliary lesions: Clinical aspects to improve the diagnosis.

Authors:  Hiroyuki Matsubayashi; Toru Matsui; Yohei Yabuuchi; Kenichiro Imai; Masaki Tanaka; Naomi Kakushima; Keiko Sasaki; Hiroyuki Ono
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 10.  Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Sergio Venanzio Setola; Elisabetta de Lutio di Castelguidone; Mauro Piccirillo; Raffaele Palaia; Roberto Grassi; Francesco Granata; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2016-11-15       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.